Опухоли женской репродуктивной системы (Jul 2014)

Imunotherapy opportunities in ovarian cancer

  • I. Zh. Shubina,
  • A. N. Gritsay,
  • L. T. Mamedova,
  • N. Yu. Sokolov,
  • S. A. Kuznetsov,
  • M. V. Kiselevskiy,
  • N. I. Lazareva,
  • V. V. Kuznetsov,
  • K. S. Titov,
  • A. P. Nikolayev

DOI
https://doi.org/10.17650/1994-4098-2013-0-3-4-110-113
Journal volume & issue
Vol. 0, no. 3-4
pp. 110 – 113

Abstract

Read online

In the last decade, accumulated evidence in favor of that ovarian cancer is an immunogenic tumor. Immunotherapy is aimed at stimulating the innate and adaptive immunity, may cause an effective response in patients with ovarian cancer. Various approaches immunotherapy include cytokinetherapy, use of monoclonal antibodies and cell therapy.

Keywords